Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Humira
Biotech
Candid flashes big ambitions with $370M debut
Candid’s launch combines fundraising and the acquisition of two biotechs, Vignette Bio and TRC 2004, along with their lead assets.
Darren Incorvaia
Sep 9, 2024 9:00am
FDA clears 2 rapid tests to track Humira, Remicade doses in IBD
Oct 3, 2023 11:33am
AbbVie knocks down earnings forecast due to IPR&D charge
Apr 6, 2023 11:10am
'Expect us to act' on M&A, AbbVie CEO says
Feb 9, 2023 2:29pm
Applied Molecular Transport's UC drug hits a roadblock
Jul 6, 2022 12:06pm
AbbVie coughs up nearly $50M for Cugene's autoimmune med
May 16, 2022 10:05am
